Lilly Holds Press Conference to Detail Leadership Changes


Lechleiter to retire; Ricks to be Lilly's 11th CEO


Eli Lilly and Company (NYSE: LLY) today announced that John C. Lechleiter, Ph.D., chairman, president and chief executive officer, will retire as president and CEO and from the company effective December 31, 2016. Lechleiter will remain non-executive chairman of Lilly's board of directors until May 31, 2017, at which time he will leave the board. Lilly's board of directors unanimously elected David A. Ricks, currently senior vice president and president, Lilly Bio-Medicines, to assume the role of president and chief executive officer and to join the board on January 1, 2017, and to become chairman of the board on June 1, 2017.

Company officials will detail these leadership changes at today's event.   


John C. Lechleiter, Ph.D., chairman, president and chief executive officer, Eli Lilly and Company; David A. Ricks, senior vice president and president of Lilly Bio-Medicines; and Bart Peterson, senior vice president of corporate affairs and communications, Eli Lilly and Company.


Wednesday, July 27, 2016 at 11:00 a.m.


Lilly Corporate Center (media are asked to please enter the main lobby at McCarty and Delaware Streets). Parking is available immediately outside of the lobby area. Please inform Lilly security that you are member of the media attending the press conference.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and C-LLY

Refer to:

Edward Sagebiel;; (317) 985-6303

Lauren Zierke;; (317) 277-6524   


Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)


Logo - 

/PRNewswire -- July 27/

SOURCE Eli Lilly and Company

News Provided by Acquire Media